tirzepatide pdufa date RTTNews | BIG WEEK AHEAD IN BIOTECH We're tracking [2] dates, [1] phase readouts, and [1] events — including: → AZN: FDA decision July 7, Tirzepatide Is Generic for What?

Findings GLP-1 receptor agonists and dual incretin agonists exert their therapeutic effects through multiple mechanisms, including enhancement of glucose-dependent insulin secretion, suppression of glucagon release, appetite reduction, and slowing of gastric emptying

Even after approval, access will be limited initially

Hormone Replacement Therapy for Men and Women Hormone replacement therapy at Simply Thrive Medical targets common imbalances such as low testosterone in men and estrogen deficiency in women

GLP-1 receptor agonists such as semaglutide and tirzepatide have already demonstrated substantial weight-loss benefits in patients with obesity